The Glaucoma Treatment Spectrum: Meds, Sustained Delivery, and MIGS | ASCRS
2022 ASCRS Annual Meeting

Satellite CME Programs

The Glaucoma Treatment Spectrum: Meds, Sustained Delivery, and MIGS


This program is designed as a compact review of key surgical and therapeutic glaucoma treatments. Faculty will explore the various considerations for MIGS, to include standalone and next-generation devices and provide the latest details on glaucoma medical therapy. The program will include live panel discussion and Q&A by our expert faculty.

The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™.

Begin Online CME Activity Now
ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from:

Mati Therapeutics
Sight Sciences

Activity Agenda

Welcoming Remarks

Leon W. Herndon, MD and Nathan M. Radcliffe, MD, ABO

Presbyopia 2022: New Use for an Old Med

Sahar Bedrood, MD, PhD, ABO

Brief Overview of MIGS Choices

Won I Kim, MD, ABO

Next-Generation MIGS

Thomas D. Patrianakos, DO

Program Chairs

Leon Herndon

Leon W. Herndon, MD

Nathan Radcliffe, MD


Jacob Brubaker. MD

Sahar Bedrood, MD

Won Kim, MD

Thomas Patrianakos, DO

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.